Key result
IV insulin infusion linked to reduced triglyceride load in hypertriglyceridemia-induced acute pancreatitis.
Why the study?
Hypertriglyceridemia is a rare and treatable cause of acute pancreatitis where timely identification and management are crucial.
Does intravenous insulin infusion reduce triglyceride load in patients with hypertriglyceridemia-induced acute pancreatitis?
Does intravenous insulin infusion reduce triglyceride load in patients with hypertriglyceridemia-induced acute pancreatitis?
Intravenous insulin infusion is an important adjunctive treatment for reducing triglyceride levels in hypertriglyceridemia-induced acute pancreatitis.
Answers are grounded in this paper and cite their sources.
May support insulin as adjunctive therapy in hypertriglyceridemia-induced pancreatitis; leaves open need for randomized confirmation.
Hypertriglyceridemia is a rare and treatable cause of acute pancreatitis. Timely identification of aetiology and management is crucial. Apart from NBM, Analgesics, Fenofibrates, Niacin, and Supportive treatment, Intravenous Insulin infusion plays an important role in reducing triglycerides load.
No takes yet. Share an insight, caveat, or question.
Vasantha Kumar Vrr (2024) studied this question. Intravenous insulin infusion reduces triglyceride load in the management of hypertriglyceridemia-induced acute pancreatitis.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: